Radnor Capital Management’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.12M Buy
5,084
+800
+19% +$221K 0.16% 148
2026
Q1
$1.27M Buy
4,284
+1,790
+72% +$532K 0.19% 133
2025
Q4
$681K Buy
2,494
+266
+12% +$72.3K 0.1% 195
2025
Q3
$602K Buy
2,228
+610
+38% +$166K 0.09% 211
2025
Q2
$446K Buy
1,618
+203
+14% +$55.2K 0.07% 236
2025
Q1
$375K Buy
1,415
+350
+33% +$86.3K 0.06% 257
2024
Q4
$247K Buy
1,065
+120
+13% +$27.6K 0.04% 286
2024
Q3
$209K Buy
+945
New +$196K 0.03% 323
2024
Q2
Sell
-945
Closed -$203K 179
2024
Q1
$203K Buy
+945
New +$199K 0.03% 312

Other funds holding CME

Radnor Capital Management's CME Position: Q2 2026 in Review

Radnor Capital Management increased its CME Group (CME) stake by 19% in Q2 2026, buying an estimated $221K and bringing the position to 5,084 shares worth $1.12M. The position accounts for 0.16% of the portfolio, ranked #148.

Radnor Capital Management first reported a position in CME in Q1 2024 and has held it in 9 quarters since. The position peaked at $1.27M in Q1 2026. 1,703 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Radnor Capital Management held 5,084 shares of CME Group worth $1.12M as of Q2 2026.
  • Radnor Capital Management bought 800 CME Group shares in Q2 2026, an estimated $221K.
  • CME Group made up 0.16% of Radnor Capital Management's portfolio in Q2 2026, its #148 holding.
  • Radnor Capital Management first reported a position in CME Group in Q1 2024 and has held it in 9 quarters since.
  • Radnor Capital Management's CME Group position peaked at $1.27M in Q1 2026.
  • 1,703 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Radnor Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.